IMRN

NASDAQ 已收盘

Immuron

0.90 USD
▲+0.05+5.86%
盘后 0.85 -5.53%
2026-11-20
市值
$7.94M
市盈率
—
EPS
-0.33
股息率
—
52 周区间
0.68 – 1.99
成交量
19.68K
Beta
0.47
目标价
—
52W 低 0.6852W 高 1.99
价格走势

公司简介

Immuron Limited, a biopharmaceutical company, engages in the research, development, and commercialization of polyclonal antibodies for the treatment of inflammatory mediated and infectious diseases in Australia, the United States, and Canada. It operates through two segments, Research and Development; and Hyper-immune Products. The company offers Travelan, an over-the-counter medicine to reduce the risk of travelers’ diarrhea and risk of minor gastrointestinal disorders, as well as a dietary supplement for digestive tract protection; ProIBS, an...